This sort of testing aims to identify distinct biochemical markers in the maternal serum that could indicate potential fetal abnormalities.Broader entry to testing NIPT genetic testing, coupled with integration of prenatal treatment, presents a chance to seize a bigger inhabitants share.Companies including Natera and Illumina are leading the way in